Article Text

SP0002 Therapy of Rheumatoid Arthritis
  1. C. Gabay1
  1. 1University Hospitals of Geneva, Geneva, Switzerland


The objective of the lecture is to provide up-to-date information on the therapy of rheumatoid arthritis, including the results of clinical trials comparing different treatment strategies, novel data on different biological agents as well as on small molecules targeting intracellular signaling pathways, the results of head to head clinical trials comparing biological agents, and the safety data from patient’s registries.

Disclosure of Interest C. Gabay Grant/research support from: Roche, Abbvie, MSD, Consultant for: Roche, Abbvie, MSD, Pfizer, BMS

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.